A novel method for generating induced pluripotent stem cell (iPSC)-derived alveolar organoids: a comparison of their ability depending on iPSC origin
Background Alveolar organoids may be useful tools in drug discovery for lung diseases, such as chronic obstructive pulmonary disease, and for studying the effects of respiratory viruses, such as severe acute respiratory syndrome coronavirus 2. Induced pluripotent stem cell (iPSC)-derived alveolar or...
Main Authors: | Min Jae Lim, Ayoung Jo, Sung-Won Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
The Organoid Society
2023-07-01
|
Series: | Organoid |
Subjects: | |
Online Access: | http://j-organoid.org/upload/pdf/organoid-2023-3-e11.pdf |
Similar Items
-
Application of an iPSC‐Derived Organoid Model for Localized Scleroderma Therapy
by: Jie Ma, et al.
Published: (2022-05-01) -
Human Pluripotent Stem Cell-Derived Alveolar Organoids: Cellular Heterogeneity and Maturity
by: Ji-hye Jung, et al.
Published: (2024-01-01) -
iPSC-Derived Organoids as Therapeutic Models in Regenerative Medicine and Oncology
by: Ali G. Turhan, et al.
Published: (2021-10-01) -
Development of lacrimal gland organoids from iPSC derived multizonal ocular cells
by: Melis Asal, et al.
Published: (2023-01-01) -
An Efficient Method for the Differentiation of Human iPSC-Derived Endoderm toward Enterocytes and Hepatocytes
by: Shimeng Qiu, et al.
Published: (2021-04-01)